Pleasanton, CA — March 31, 2003 — Pharmaceuticals giant AstraZeneca has expanded its use of a content management solution from Documentum to include Web content management and digital asset management, the provider reported today.
A longtime Documentum customer, AstraZeneca, which spends more than $10 million every business day in research and development, employs 55,000-plus people and has sales in more than 100 countries. The company has healthcare sales of over $17.8 billion.
The pharmaceuticals company uses the Documentum platform to share best practices in the discovery of new drugs and promote product knowledge transfer through intranet applications.
Before standardizing on the Documentum platform, AstraZeneca managed all its Internet and intranet sites individually, which made it difficult to leverage and repurpose existing content, including such digital assets as brochures, presentations, graphics and advertising copy.
The Documentum products are at the foundation of the new AstraZeneca Web Content Management Service, dubbed "Azgard," designed to help the company's sales and marketing organizations to accelerate the creation and publishing of Web sites and digital assets for a growing number of Internet and intranet sites, as well as to lower publication costs.
Documentum said its solution would help AstraZeneca reuse digital assets for cost savings, lower Web maintenance costs, accelerate user training, deploy new Web sites more quickly and ensure regulatory compliance throughout its Web sites.
"Our positive experience with Documentum over the last few years led us to standardize on the Documentum platform throughout our organization," said Steve Atkinson, enterprise software manager at AstraZeneca. "Deploying Documentum's Web content management and digital asset management technologies allows us to reduce operating costs by deploying a single platform within a secure environment."
